NATURES SUNSHINE PRODUCTS INC · Drugmakers

NATR

Low riskNext report: Around Nov 5 (est.)

View price ↗

The short version

A profitable company with steady sales. Institutions are adding.

Going well

Profitable
Brings in more cash than it spends
Buying back shares: share count down 4.4% in 3 years

Money moves

No insider buying or selling in the last 30 days
Institutions added 3.6% to their holdings in the quarter ending June 2026 (70 bought, 69 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$12.29+1.4% that day

Company value: $216M; Share price times all shares
Price vs profit (P/E): 12.2x; You pay about $12 for each $1 of yearly profit
Price vs sales: 0.44x; Company value is 0.44 times a year of sales
Cash vs value: 38%; A big cushion: cash is a large part of what the company is worth

From NATR's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$117.0M+1.9% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $492.0M, up 6.8% from the 12 months before. Over 5 years, sales grew about 4.5% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of NATR. Starting points are the company's recent numbers.

Sales growth+7% a yearRecently: +6.8% a yearProfit margin4%Last 12 months: 3.7%P/E at the end12xToday: 12.2x. Many steady companies trade at 12x to 25xShare count change-1% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$690M

Profit in 5 years$28M

Price these guesses point to$19.80+61% vs $12.29 todayAbout +10% a year, before dividends

What today's price needs: with a 4% margin and a 12x P/E, sales could shrink about 2.7% a year for 5 years and still match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

4/6Mixed

PassDebt under half of equityNot relying on borrowed money.No debt reported
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.4.1%
MissProfitable every yearSteady profits, not one good year.7 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$28.8M
PassShare count not growingNot diluting owners. Falling means buybacks.-4.4% in 3 years
PassGross margin 40%+Pricing power: sells for well above what it costs to make.72.4%

Revenue: $480.1M; +5.7% vs prior year
5-year growth: +4.5%/yr; revenue, per year
Total debt: None
Current ratio: 2.28x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+. A checklist is a starting point for research, not a verdict.